Biological Age Testing Explained: Epigenetic Clocks, Telomeres, and What the Tests Actually Measure

What “biological age” actually means

Chronological age counts birthdays. Biological age attempts to measure accumulated cellular and molecular damage — the rate at which your biology is aging relative to your calendar. Two people at age 50 can have biological ages of 42 and 61. The divergence is driven by genetics (approximately 25%) and modifiable lifestyle factors (approximately 75%). This means the majority of your aging rate is within your control — but measuring it requires molecular testing, not a mirror.

The epigenetic clock landscape

Horvath (2013): first-generation clock, trained on methylation patterns across 353 CpG sites. Accurate for age estimation but a poor predictor of mortality or disease. Hannum (2013): blood-specific clock with similar first-generation limitations. PhenoAge (2018, Levine): trained on clinical biomarkers plus methylation. Better mortality correlation, especially for age-related disease outcomes. GrimAge (2019, Lu): trained on smoking pack-years plus plasma protein signatures. Strongest all-cause mortality predictor of any clock. Hazard ratio of 2.45 per decade of age acceleration (Nature Aging, 2019). Most consumer biological age tests use first-generation Horvath clock — less predictive of mortality than GrimAge.

Why GrimAge is the gold standard

GrimAge predicts time-to-death better than any other epigenetic clock in direct comparison studies. It captures: DNA methylation patterns, plasma DNAmGDF15 (a mortality biomarker), and DNAmPACKYRS (a biological smoking signal that persists even in never-smokers exposed to oxidative stress). In the UK Biobank cohort (n=13,451), GrimAge was the strongest predictor among 9 clock models tested — hazard ratio 1.09 per year of age acceleration after adjustment for all confounders including chronological age, BMI, smoking status, and comorbidities. This is the clock that matters for longevity monitoring.

Telomere length: what it measures and its limitations

Telomeres are the protective caps on chromosome ends. They shorten with each cell division and with oxidative stress. Critically short telomeres trigger cellular senescence — the zombie cell state that drives inflammation and tissue dysfunction. Testing method: qPCR (most common, cost-effective, measures average telomere length across white blood cells) or FISH (more precise, measures individual chromosomes, expensive). Key limitation: high intra-individual variability. A single telomere length test can vary 15–20% on retesting due to biological and methodological noise. Most useful as a trend marker with 3 or more data points, not a one-time snapshot. Telomere length provides information orthogonal to epigenetic clocks — together they give a more complete picture.

Proteomics-based biological age

SomaLogic’s SomaScan platform measures approximately 7,000 plasma proteins simultaneously. SomAge (derived from SomaScan data) shows strong correlation with GrimAge and predicts disability onset. Olink proximity extension assay offers panels of 92 to 3,000 proteins with high sensitivity. High predictive power but expensive ($800–$3,000 per test). Most relevant for longevity-focused patients tracking intervention response at high resolution. Proteomics captures the downstream functional output of epigenetic changes — providing a different biological layer than methylation clocks alone.

How to interpret your results

Age acceleration: biological age minus chronological age. Positive means aging faster than calendar. Negative means aging slower than calendar. Context matters significantly: GrimAge acceleration of +5 years at age 45 means different absolute risk than +5 years at age 65, because baseline mortality risk is lower at 45. Relative cohort comparison — what percentile of your age group — is more actionable than the absolute number for most patients. Target: delta aging of -1 year or better (biological age decreasing relative to chronological age over time).

What interventions actually move the clocks

Caloric restriction (20% reduction): GrimAge deceleration signal in multiple rodent models; human data emerging from the CALERIE trial. Exercise (150 minutes per week aerobic plus 2x resistance training): mean biological age reduction of 1.8 years at 12 months (Dunn et al, 2019) — the single most consistent intervention in human data. Quality sleep (7–9 hours, low fragmentation): poor sleep adds 1.5–2 years to GrimAge in observational data — one of the highest-impact modifiable factors. Metformin: TAME trial ongoing; observational data shows GrimAge deceleration in diabetic patients. Rapamycin: mTOR inhibition extends lifespan in every mammalian model tested; human longevity trial data preliminary.

WellSpry’s biological age panel

The WellSpry biological age panel includes GrimAge and PhenoAge together — a dual-clock approach that captures both the strongest mortality predictor and the best disease-trajectory correlator. Telomere length via qPCR provides a third data dimension. Plasma biomarker panel supports clock interpretation with context on metabolic and inflammatory status. Physician interpretation call is included — these results require clinical context to act on. Annual retest is recommended to track delta aging and determine whether interventions are measurably slowing your biological clock.

WellSpry's biological age panel uses GrimAge and PhenoAge together with telomere length and a plasma biomarker panel. Physician interpretation included. Annual retesting tracks your delta aging trend.

Frequently Asked Questions